Clinical feature: 

Definition: This group covers vascular damages clustered in families.

Literature: 

Dashti SR et al. (2006) Molecular genetics of familial cerebral cavernous malformations.
Mahr AD et al. () Epidemiology of Wegener's granulomatosis: Lessons from descriptive studies and analyses of genetic and environmental risk determinants.
Sun H et al. (2006) The interaction between pathogens and the host coagulation system.
Uhlmann K et al. (2006) Genetics of diabetic retinopathy.
Bhoday J et al. (2006) The molecular mechanisms of vascular restenosis: Which genes are crucial?
Weiler CR et al. (2006) Genetic test indications and interpretations in patients with hereditary angioedema.
Orlacchio A et al. () Research actuality in the genetics of stroke.
Kim SH et al. (2006) Genetic mechanism of aspirin-induced urticaria/angioedema.
Hankey GJ et al. (2006) Potential new risk factors for ischemic stroke: what is their potential?
Szolnoki Z et al. (2006) Gene-gene and gene-environment interplay represent specific susceptibility for different types of ischaemic stroke and leukoaraiosis.
Tsai HM et al. (2006) The molecular biology of thrombotic microangiopathy.
Krischek B et al. (2006) The genetics of intracranial aneurysms.
Nordlie MA et al. (2006) Molecular aspects of ischemic heart disease: ischemia/reperfusion-induced genetic changes and potential applications of gene and RNA interference therapy.
Topol EJ et al. (2006) The genetics of heart attack.
Thornton S et al. (2006) Contribution of angiogenic genes to the complex genetic trait underlying Kawasaki disease.
Zambon A et al. (2006) Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease.
Nguyen T et al. () Variability of response to clopidogrel: possible mechanisms and clinical implications.